Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Neal
Beverley J Hunt

JAMA

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
JAMA|October 12, 2023
Precision in Transfusion MedicineMatthew D Neal, Beverley J Hunt
JAMA|December 8, 2025
An Oasis in the Platelet Desert?Matthew D Neal, Philip C Spinella, Lucy Z Kornblith
JAMA|March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
JAMA|January 18, 2022
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical TrialJeffrey S Berger, Lucy Z Kornblith, Michelle N Gong, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
JAMA|October 12, 2023
Precision in Transfusion MedicineMatthew D Neal, Beverley J Hunt
JAMA|December 8, 2025
An Oasis in the Platelet Desert?Matthew D Neal, Philip C Spinella, Lucy Z Kornblith
JAMA|March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
JAMA|January 18, 2022
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical TrialJeffrey S Berger, Lucy Z Kornblith, Michelle N Gong, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
Pageof 1